44 results
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... (TB) • Disseminated ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... IDSA #management #pharmacology
IDSA - Prophylaxis to Prevent First Episode of Opportunistic Disease in HIV-AIDS
 • Pneumocystis pneumonia (PCP)
Opportunistic Disease in HIV-AIDS ... (TB) • Disseminated ... Papillomavirus (HPV ... Hepatitis A virus (HAV ... IDSA #management #pharmacology
IDSA Recommendations for Preventing Human Papillomavirus Infections and Cervical Cancer Screening for Women with in HIV-AIDS
Recommendations
Women with in HIV-AIDS ... known to have HIV ... Schedules • HPV ... #Treatment #management ... #HIVAIDS #pharmacology
Initiation of ART in HIV patients with Opportunistic Infections
 • Pulmonary TB and CD4 cell count
Initiation of ART ... in HIV patients ... • Pulmonary TB ... of starting OI treatment ... Therapy #HAART #HIV
Blurry vision in a patient with HIV/AIDS
Anterior Segment:
 • Herpes zoster ophthalmicus
 • Keratitis (HSV, Staph,
a patient with HIV ... /AIDS Anterior ... , VZV, TB*, Histo ... Posterior Segment: • HIV ... retinal necrosis (ARN
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
Recommendations for Preventing ... in HIV-AIDS Preventing ... in response to ART ... #Treatment #management ... #HIVAIDS #pharmacology
Cytomegalovirus (CMV) in HIV-AIDS Patients
Cytomegalovirus (CMV): double-stranded DNA virus, herpesvirus family.
CMV infection: virus isolation or detection
Cytomegalovirus (CMV) in HIV-AIDS ... any patient with HIV ... Pancreatitis • Pulmonary ... association with PJP/TB ... Cytomegalovirus #CMV #HIV
IDSA Recommendations for Preventing and Treating HHV-8 Diseases—Kaposi Sarcoma (KS), Primary Effusion Lymphoma (PEL), Multicentric Castleman’s
and Treating HHV ... Disease (MCD) in HIV-AIDS ... and uncontrolled HIV ... opportunistic #infections ... #HIVAIDS #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
: • HIV • Recent ... infectionPulmonary ... pulmonaryHIV ... TST or IGRA HIV ... : • HIV-infected
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
: • HIV • Recent ... infectionPulmonary ... pulmonaryHIV ... TST or IGRA HIV ... : • HIV-infected